U.S. trade deals may not be spurring the large drug price increases and shifts away from lower-cost generics in U.S. trading partners that many predicted. 

Overview The gravest health threats facing low- and middle-income countries are not the plagues, parasites, and blights that dominate the news cycle and international relief efforts. They are …